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Introduction: The introduction of highly active antiretroviral therapy has so far led to a comparable reduction in disease progression 
and restoration of normal functioning of reproductive system in female living with HIV infection. The main objective of this study 
was to find out the magnitude of pregnant and its determinants among ART‑registered clients in Simiyu region, Tanzania.
Methods: We used a retrospective cohort study of HIV/AIDS women initiated ART in Simiyu region from 2005 up to 2018. 
Kaplan–Meier survival graphics were used to explain the difference pregnancies experiences among different groups. Cox 
proportion hazard was used for model building to determine the predictors of pregnancy.
Results: A total number of 525 women became pregnant, giving an overall incidence rate of 3.1/100 person year at 
risk (PYAR) (95% CI 2.84–3.37). The incidence of pregnant was higher between the age 15 and 29 years (5.86/100 
PYAR, 95% CI: 5.23–6.55). Cohabited and those who are married were associated with high incident rate of pregnant 
(5.62/100 PYAR, 95% CI: 1.81–17.43 and 4.16/100 PYAR, 95% CI: 3.79–4.57). Weight >55 kg were associated with 
high incidence of pregnant (5.03 PYAR, 95% CI: 4.54–5.57), and WHO stage one have high incidence of pregnant 
(11.14/100 PYAR, 95% CI: 9.95–12.47).
Conclusion: Young age and being healthier were the main predictors of pregnancy after ART initiation in this population. 
Policy for integration of family planning services into HIV care and treatment clinics should be strengthened but focused to 
young women. More follow‑up is needed for pregnant and newborn outcome.
Key words: HAART; HIV/AIDS; pregnancy incidence.
Introduction
The decline of the new HIV infections among adults observed 
globally has rapidly slowed in the recent years. In sub-Saharan 
Africa, adolescent girls and young women accounted for 25% of 
the new HIV and adult women accounted for 56% of the new HIV 
infections.[1] In Tanzania, it was estimated that approximately 
1.35 million people were infected with HIV in the country by the 
year 2016. Women were more affected, with an HIV prevalence 
of 6.3% versus 3.9% among men.[2] In 2017, it was reported that 
up to 80% [61–>95%] of pregnant women living with HIV in the 
country had an access to antiretroviral medicines that prevents 
transmission of HIV infection from mother to child.[3]
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The introduction of highly active antiretroviral 
therapy (HAART) has so far led to comparable reductions in 
disease progression and mortality. This results into backup 
of normal human functioning of various body organs and 
system such as reproductive system.[3-6]
Currently there is evidence that initiating ART among women 
of reproductive age increases child bearing desire and sexual 
activities. It was also found that increased numbers of sexually 
active female attending care and treatment clinic (CTC) are 
reported to use modern contraceptive methods.[7]
Access to HAART and the prevention of mother to child 
transmission of HIV (PMTCT) services has been one of the 
important determinants of fertility desires and behaviors.[8] 
Thus, availability of HAART encouraged patients to have 
children as their risk of transmitting the virus has been 
substantially decreased.[9] It is possible that the rapid 
improvements in health and quality of life that take place with 
HAART initiation lead to increased sexual activity, particularly 
for those with stable partnerships.[10] However, studies show 
that treatment of HIV patient with HAART does not influence 
the desire for having children by the patients using the 
drugs.[11] Researches conducted in developed countries show 
that HIV infection is associated with a decline in fertility and 
that HAART initiation reverses this decline.[12,13] Incidence 
of pregnancy among women receiving routine HIV care and 
treatment has increased and is almost comparable to that in 
the general population.[14] It is higher after initiating HAART 
compared to prior to could be due to an improved immune 
status or reduced HIV viral load in the body, and this tended 
to increase when both women and their spouses desired 
more children and decreased with older age.[15]
Although researchers have shown many important insights on 
the association between HAART use and childbearing desire, 
little work has been carried out to find out the impact of 
its use and occurrence of pregnancy in Tanzania. This study 
aimed at finding out the magnitude of pregnancy and its 
determinants among CTC-registered women in Simiyu region. 
The findings of this study will lead to the development of a 
conceptual framework on HIV women unmet needs, which 
will be used by policy makers.
Materials and Methods
Study design and population
This was a retrospective cohort study of HIV-infected women 
initiated with HAART from three districts, namely Maswa, 
Bariadi, and Busega in Simiyu region between 2005 and 
2018. Eligibility was based on reproductive age between 15 
and 49 years.
Study area
Simiyu Region covers an area of 23,807.7 km2 and administratively 
it consists of 5 district councils and 1 town council, 12 divisions, 
111 wards, 475 villages, and 17 Mitaa (in Bariadi Town Council). 
The region is located North of Tanzania and South East of Lake 
Victoria; it lies between latitude 2°1′′ and 4° South of Equator 
and between 33°3′′ and 35°1′′ East of Greenwich.
The region is bordered by Manyara and Singida regions in 
the east, south by Shinyanga region, west by Mwanza region, 
and north by Mara region. Also, eastern and part of northern 
boundaries lie the famous Serengeti National Park.
HIV/AIDS care and treatment started in Simiyu 2005 at Maswa 
District Hospital. Currently, there are 53 care and treatment 
centers of 214 health facilities (24.7%) in the region.
The HIV prevalence in the region is estimated to be 
3.9% (THIS2016/17) below the National average that is 4.7%. 
According to Regional HIV and AIDS profile, there are 4 
hospitals, 17 health centers, and 193 dispensaries, making 
a total of 214 health facilities in the region.
Subject characteristics
The anticipated number of clients was 4872 with the age 
ranging from 15 to 49 years regarded as reproductive age 
range. Those women identified to be HIV positive and 
initiated ART in the 25 CTCs.
Women with age <15 and >49 years were excluded from 
the study. Women with missing observation such as weight, 
World Health Organization (WHO) stage, and pregnancy 
status were also excluded.
Sampling and data collection
We included all 25 health facility providing care and treatment 
for HIV/AIDS clients in Busega, Bariadi, and Maswa districts. 
Data were extracted from the electronic database CTC2 and 
exported for analysis to the excel software. At the time of 
data collection, we found a cumulative total of 16,344 clients 
enrolled. After checking for eligibility, only 4872 were eligible 
and sampled for the study.
The electronic database (CTC2) contained several files. We 
extracted three files: one that contained the sociodemographic 
characteristics such as sex, date of birth, height, and marital 
status; the second file that contained the medical characteristics 
and progression of the client such as date of visit, weight, WHO 
stage, and pregnancy status; and the third that showed the final 
status of the patient at the time of data extraction.
Data clerks in the respective clinic were trained for data 
collection from the electronic database. Data were screened 
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for missing value and those observed with the missing 
values were removed. All collected data were stored in 
an Excel data sheet (Microsoft corporation, One Microsoft 
way/Ridmond/WA 98052 USA) in a computer.
Operation definition of variable
Indicator variable: The indicator variable in this study that was 
used in modeling was pregnancy status, that is, a variable is 
equal to 0 or 1, where a value of 1 indicates that the women 
become pregnant at a certain time during observation, 
whereas a value of 0 indicates that the women does not 
experience pregnancy.
Incident of pregnancy: Incidence of pregnancy was considered 
in this study as when the indicator variable had the value of 
1 during follow-up period. This variable was measured by 
using person years at risk time (PYAR).
Categorical variable: In this research, all categorical variables 
were given values to represent the membership in form of 
values 1, 2, 3, and 4. Categorical variables used were marital 
status and WHO stage.
Continuous variable: In this study, variables were measured 
on a well-defined, cardinal scale, such as age in years and 
immunology as in CD4 count.
Time to event: In this research, it was a time when the women 
free from pregnancy identified to have HIV infection and 
start HAART until when she becomes pregnant, and it was 
measured by person year.
Dependent variable: The dependent variable in this research 
was the incidence of pregnancy and this was considered when 
the women become pregnant at first time after HAART start.
Independent variable: In this study, variables such as weight, 
WHO stage, CD4 count, and district of residency were used 
as independent variables and entered in to the model.
Data analysis
Data from Excel were transferred to  Stata software 
version 12.0 (StataCorp 4905 Lakeway Drive College 
Station, Texas 77845 USA, 800-STATA-PC) for analysis and 
transformation was carried out. Categorical variables 
were grouped and given values of 1, 2, 3…, and measured 
using proportion. Continue variables were given ranges 
and converted into group by given values of 1, 2, 3…, and 
measured using proportion, mean, and median.
Kaplan–Meier survival graphics were used to explain different 
pregnancy experiences among groups. The log-rank, Wilcoxon, 
and Tarone–Ware tests were used to test the hypothesis of 
no-difference pregnancy experience among groups.
Cox proportion hazard was used for model building to 
determine the predictors of pregnancy and graphical method 
was used for Cox model diagnostics.
Results
Baseline characteristics
A total of 4872 women of 16,344 women (29.8%) were 
eligible and they were enrolled in the study. The mean 
age for this population was 34 years ± 8 standard 
deviation (SD).
Among 4872, 3070 (63%) were married, 886 (18%) weighed 
<45 kg, and 3986 (72%) weighed >45 kg. 736 (15.11%) were 
in WHO stage IV, whereas 1494 (30.67%) had CD4 count >500 
copies per deciliter [Table 1].
Of the 4872 population, 524 (11.4%) women experienced 
the event of having pregnant during the entire follow-up 
period [Table 2].
Incidence rate of pregnancy
A total number of 525 women became pregnant 
over 16679.17591 person year of follow-up, giving an 
overall incidence rate 3.1/100 PYAR (95% CI: 2.84–3.37). The 
incidence rates of pregnant by sociodemographic and clinical 
character are shown in Table 3.
The incidence of pregnancy was higher between the age 15 
and 29 years (5.86/100 PYAR, 95% CI: 5.23–6.55) having five 
times higher than the age >40 years (0.7/100 PYAR, 95% 
CI: 0.49–0.99).
Cohabited and those who are married were associated with 
high incident rate of pregnant (5.62/100 PYAR, 95% CI: 
1.81–17.43 and 4.16/100 PYAR, 95% CI: 3.79–4.57) as compared 
to those who are single and divorced (1.81/100 PYAR, 95% CI: 
1.39–2.35 and 0.69/100 PYAR, 95% CI: 0.45–1.04).
Weight >55 kg were associated with high incidence of 
pregnancy being five times higher as compared to lower 
weigh (5.03 PYAR, 95% CI: 4.54–5.57), and WHO stage I have 
11 times high incidence of pregnancy compared to other 
WHO stages (11.14/100 PYAR, 95% CI: 9.95–12.47).
In this population, having CD4 cell count >200 copies per 
deciliter was associated with high incidence of pregnancy 
[Table 4].
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Figures 1–4 show a difference in probability curve within 
different category of age, weight, WHO stage, and CD4 cells 
count.
Predictors of pregnancy
Putting age into classes in this population was associated 
with high rate of pregnancy. Starting ART with age 
Table 1: Demographic characteristics, numbers, become pregnant, censored, proportion (percent, total) of women receiving HAART 
in Simiyu region, 2005-2018
Variable Number Become pregnant Proportion pregnant (%) Censored Proportion censored (%) Total frequency
Median age 34.2±7.8
Age
15‑29 1617 324 58.48 1293 29.94 1617 (33.19)
30‑39 2007 197 35.56 1810 41.92 2007 (41.19)
40‑49 1248 33 5.96 1215 28.14 1248 (25.61)
Marital status
Cohabited 16 3 0.54 13 0.30 16 (0.33)
Divorced/widowed 882 24 4.33 858 19.87 882 (18.10)
Married 3070 469 84.66 2601 60.24 3070 (63.01)
Single 904 58 10.47 846 19.59 904 (18.56)
District of treatment
Bariadi 1759 270 48.64 1482 34.38 1751 (36.00)
Busega 1071 94 17.00 977 22.66 1071 (22.02)
Maswa 2042 190 34.36 1852 42.96 2042 (41.98)
Weight
<45 886 19 3.43 867 20.08 886 (18.19)
45‑55 1875 143 25.81 1732 40.11 1875 (38.49)
55+ 2111 392 70.76 1719 39.81 2111 (43.33)
Who stage
1 941 313 56.50 628 14.54 941 (19.31)
2 1663 157 28.34 1506 34.88 1663 (34.13)
3 1532 64 11.55 1468 34.00 1532 (31.44)
4 736 20 3.61 716 16.58 736 (15.11)
Cd4 count
<50 320 14 2.53 306 7.09 320 (6.57)
50‑199 975 42 7.58 933 21.61 975 (20.01)
200‑349 1158 102 18.41 1056 24.46 1158 (23.77)
350‑499 925 123 22.20 802 18.57 925 (18.99)
>=500 1494 273 49.28 1221 28.28 1494 (30.67)
Sources: CTC2 Database from Care and Treatment Clinics in Simiyu 2005‑2018
Table 2: The number of subject, events, analysis time, incidence of pregnancy, and 95% confidence interval estimates for 
sociodemographic characteristics variables among female in care and treatment clinics in Simiyu region, 2005-2018
Variable Number of female Become pregnant PYAR (per 100 PRAY) PR (per 100 PRAY) PR (95% CI)
Crude 4709 525 166.7918 3.15 2.88‑3.43
Age
15‑29 1558 304 50.9017 5.97229 5.34‑6.68
30‑39 1944 190 71.9931 2.63914 2.29‑3.042
40‑49 1207 31 43.8969 0.70620 0.50‑1.00
Marital status
Cohabited 16 3 0.4914 6.10514 1.97‑18.93
Divorced/widowed 865 22 31.5428 0.69746 0.46‑1.06
Married 2971 445 104.6621 4.25178 3.87‑4.67
Single 857 55 30.0954 1.82752 1.40‑2.38
District of treatment
Bariadi 1722 263 66.2744 3.9683 3.52‑4.48
Busega 1061 93 33.5107 2.7752 2.26‑3.40
Maswa 1922 169 66.8868 2.5267 2.17‑2.94
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ranging from 15 to 29 years in this population was 
found to be significant predictors of pregnancy in 
multivariate (HR = 4.92 [95% CI: 3.33–7.24]), compared to 
age 40 years and above.
Body weight stratified by categories was significantly 
associated with occurrence of pregnancy. Starting ART 
with body weight high at 55 kg was associated with 
three times hazard of pregnancy compared with lower 
weight (HR = 2.67 [95% CI: 1.63–4.36]).
Disease stage based on WHO staging was the predictors 
of pregnancy in this population. WHO stage I during start 
of ART was significantly associated with 12 times higher 
hazard of pregnancy as compared to both stages 3 and 
4 (HR = 11.76 [95% CI: 6.46–21.41]) [Table 4].
Table 3: The number of subject, events, analysis time, incidence of pregnancy, and 95% confidence interval estimates for medical 
characteristics variables among female in care and treatment clinics in Simiyu region 2005-2018
Variable Number of female Become pregnant PYAR (per 100 PRAY) PR (per 100 PRAY) PR (95%CI)
Weight
<45 851 19 29.05 0.65 0.42‑1.03
45‑55 1824 139 65.79 2.11 1.79‑2.49
55+ 2034 367 71.95 5.10 4.61‑5.65
Who stage
1 917 302 26.64 11.33 10.13‑12.69
2 1597 144 55.04 2.62 2.22‑3.08
3 1475 59 52.48 1.12 0.87‑1.45
4 720 20 32.63 0.61 0.40‑0.95
Cd4 count
<50 300 12 7.16 1.68 0.95‑2.95
50‑199 939 39 27.54 1.42 1.03‑1.94
200‑349 1123 98 40.95 2.39 1.96‑2.92
350‑499 910 122 34.09 3.58 3.00‑4.27
>=500 1437 254 57.05 4.45 3.94‑5.03
Table 4: Estimated hazard ratio (cHR and aHR) and 95% confidence intervals for age, marital status, district of residence, weight, 
WHO stage and Cd4 count categories from female enrolled into care and treatment clinics, 2005-2018
Variable Being pregnant CHR [95% confidence interval] AHR [95% confidence interval]
Age
15‑29 304 8.42 [5.82‑2.19] 4.92 [3.33‑7.24]
30‑39 190 3.57 [2.44‑5.22] 2.96 [1.99‑4.39]
40‑49 31 1 1
Marital status
cohabited 3 2.94 [0.92‑9.40] 1.07 [0.37‑3.37]
Divorced/widowed 22 0.38 [0.23‑0.63] 0.28 [0.17‑0.45]
Married 445 2.32 [1.75‑3.07] 0.57 [0.42‑0.75]
Single 55 1 1
Weight
<45 19 1 1
45‑55 139 3.19 [1.97‑5.15] 1.46 [0.89‑2.42]
55+ 367 7.82 [4.93‑12.40] 2.67 [1.63‑4.36]
Who stage
1 302 23.26 [14.51‑37.31] 11.76 [6.46‑21.41]
2 144 5.03 [3.10‑8.15] 4.05 [2.23‑7.38]
3 59 2.15 [1.28‑3.61] 1.70 [0.91‑3.17]
4 20 1 1
Cd4 count
<50 12 1 1
50‑199 39 0.87 [0.46‑1.66] 0.60 [0.31‑1.15]
200‑349 98 1.47 [0.80‑2.67] 0.71 [0.39‑1.30]
350‑499 122 2.19 [1.21‑3.96] 0.78 [0.43‑1.44]
>=500 254 2.72 [1.52‑4.85] 0.92 [0.51‑1.67]
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Discussion
Simiyu is one of the region providing care and treatment 
services to patient identified with HIV/AIDS since 2005. 
Due to scaling to HAART and accessibility to clients in 
Tanzania, the line of HIV infection has shifted from a lethal 
to a chronic disease as a result of this.[4,6] This encouraged 
women to have children as their risk of transmitting the 
infection was substantially decrease;[9] thus, patients 
with HIV infection consider having offspring as do other 
women without the infection within the reproductive 
age.[12,16,17]
This study was an attempt to identify the magnitude and the 
factors determining the occurrence of pregnancy among HIV 
patient initiated HAART.
The incidence of pregnancy in this study found to be 3.15/100 
PYAR; this highlights that women infected with HIV/AIDS on 
stable ART become pregnant like their neighbor who are 
not infected with HIV. This implies that there is an increase 
in probability of maternal to child transmission of the virus; 
thus, they need services such as PMTCT and family planning. 
Our study is similar to other studies that documented HIV 
women of reproductive age become pregnant when initiated 
Figure 2: Kaplan‑Meier plots of cumulative probability of pregnancy after 
ART start in simiyu region by Weight
Figure 1: Kaplan‑Meier plots of cumulative probability of pregnancy for HIV/
AIDS women after ART start in Simiyu region  by age category
Figure 4: Kaplan‑Meier plots of cumulative probability of pregnancy after 
ART start in simiyu region by Cd4 Count
Figure 3: Kaplan‑Meier plots of cumulative probability of pregnancy after 
ART start in simiyu region by WHO stage
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ART.[10,12,15,18-22] However, our magnitude is low compared from 
other countries in Sub-Saharan Africa[12,14] and Ethiopia.[23] In 
contrast, some studies observed that initiation of HAART was 
not associated with occurrence of pregnant.[24]
This study provides significant evidence that the incidence 
of pregnancy is higher from age 15 to 39 years. This is the 
normal age of highly biological reproductive period when the 
women desire more offspring. When the women infected with 
HIV and has an advanced disease, the biological reproductive 
system is impaired and the physiological/psychological desire 
for bearing children is lost.[25-27] After initiating HAART, the 
normal functioning of reproductive system is reverted and 
the women become normal.[15,28] This necessitates that the 
region put more efforts for primary prevention of HIV for 
the young group who are not infected to stay free from HIV 
and those who are affected should kept on lifelong ART and 
keeping close follow-up to their newborns. Our finding was 
similar to other studies showing that age was a significant 
predictor of pregnancy,[10,12,14,15,19,20,22] because this also was 
a predictors of fertility desire.[17]
Marital status is the clear indicator of sexual activity of an 
individual. This study showed that the incidence of pregnancy 
is more among cohabited/married women. Nevertheless, 
it has no statistical significance in a multivariate analysis. 
This entails that like other none infected couples, they need 
reproductive health services such as family planning, PMTCT, 
and social and behavioral communication changes. However, 
our study was dissimilar with the several studies, which 
show that marital status was significantly associated with 
occurrence of pregnancy;[10,14,23] however, what is needed is 
the frequency sexual contact[29] which does not depend on 
marital status.
Weight is a proximal measure of progression of the disease 
and nutrition status of an individual. This study shows 
that weight was significantly associated with occurrence 
of pregnancy. This entails that for the women to become 
pregnant should have good nutritional status. Thus, our work 
is to promote nutrition promotion to women initiated HAART; 
thus, they cannot go to advanced stage of the disease. And 
for those with advanced disease initiated HAART and getting 
better nutrients can become healthier reverting normal 
reproductive system. Our study was dissimilar to the studies 
that did not show the association of weight and occurrence 
of pregnancy.[12]
The WHO set criteria for classification of the severity of 
disease in patients with HIV/AIDS. This study provides 
evidence that women with less-advanced disease (stages 1 
and 2) were significantly more likely to become pregnant 
compared to women with advanced stage of disease (stages 
3 and 4). Findings indicate in women with less-advanced 
stage of the disease; their reproductive systems are well 
functioning, both biologically and physiologically. Thus, 
once there is sexual relation between the women and their 
partner, the chance of getting pregnant is high. Our work is 
to improve counseling the women when to get pregnant for 
those who need child bearing. This study had similar findings 
with other work indicating that WHO stage was significantly 
associated with incidence of pregnancy.[10]
When women are infected with HIV virus, it depletes 
the immunity. CD4 cells count is used to measure the 
immunological pattern of the patient infected with HIV. 
This study shows that CD4 cells count was not significantly 
associated with incidence of pregnancy in multivariate 
analysis. These findings were not similar with the findings 
of study conducted in Uganda, which shows that the levels 
of CD4 count were one of the determinants of pregnancy.[14] 
However, study conducted by Mmbaga et al.[30] showed that 
fertility desire increases when CD4 cells count are higher, 
which subsequently increases the possibility of HIV infected 
women to became pregnant.
Limitation of the study
In view of the fact that this is a retrospective study using 
already recorded data, some of the variables are missing 
such as family planning uptake, body mass index, adherence 
to ART, missing weight, CD4 count, and unknown pregnancy 
status; thus, some of the observation was deleted and this 
could affect the predictors of pregnant.
Conclusion
With regard to this finding, the incidence of pregnant in 
Simiyu region among women taking antiretroviral treatment 
was found to be considerably present in young women.
Predictors of pregnant after ART initiation in this population 
were young age and being healthier.
 Recommendation
Policy for integration of family planning services into HIV 
CTCs should be strengthened but focused on young women. 
More follow-up study is needed to see the pregnant and 
new-born outcome.
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